UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036675
Receipt number R000036918
Scientific Title Feasibility of efficacy and safety of double-tract reconstruction after laparoscopic proximal gastrectomy for gastric cancer: a phase II study
Date of disclosure of the study information 2019/05/08
Last modified on 2019/05/08 11:03:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility of efficacy and safety of double-tract reconstruction after laparoscopic proximal gastrectomy for gastric cancer: a phase II study

Acronym

LPG double tract

Scientific Title

Feasibility of efficacy and safety of double-tract reconstruction after laparoscopic proximal gastrectomy for gastric cancer: a phase II study

Scientific Title:Acronym

LPG double tract

Region

Japan


Condition

Condition

Gastric cancer in the upper third

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of efficacy and safety in double-tract reconstruction after laparoscopic proximal gastrectomy for gastric cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Weight loss rate 6 months after surgery

Key secondary outcomes

Surgical process (operative time, intraoperative bleeding, the number of ports, the use of the saturation, cost, the rates of laparotomy transition), postoperative course (oral intake, length of stay, inflammatory findings, the rates of late complications, stenosis, usage rate of PPI, incidence rate of GERD).


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Laparoscopic proximal gastrectomy with double-tract reconstruction

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Histologically proven gastric carcinoma in the upper third
2. Performance status 0 and 1
3. Aged 20 to 85 year
4. No history of surgery for gastric cancer (Endoscopic treatment is tolerant)
5. Plt => 100,000/mm3
Creatinine <= 2.0 mg/dl
AST <= 200 IU/L
ALT <= 200 IU/L
T-bil <= 2.0 mg/dl
Hb => 8.0 g/dl
6. Patients who gave written informed consent before entry in this study

Key exclusion criteria

1. Ischemic heart disease
2. Liver cirrhosis, active hepatitis
3. Interstitial pneumonia
4. Haemodialysis
5. Both malignant disorder
6. Severe abdominal adhesion
7. Doctor's decision not to register to this regimen

Target sample size

22


Research contact person

Name of lead principal investigator

1st name Toshiyasu
Middle name
Last name Ojima

Organization

Wakayama Medical University, School of Medicine

Division name

Second Department of Surgery

Zip code

641-8510

Address

Kimiidera 811-1, Wakayama

TEL

0734410613

Email

tojima@wakayama-med.ac.jp


Public contact

Name of contact person

1st name Toshiyasu
Middle name
Last name Ojima

Organization

Wakayama Medical University School of Medicine

Division name

Second Department of Surgery

Zip code

641-8510

Address

Kimiidera 811-1, Wakayama

TEL

0734410613

Homepage URL


Email

tojima@wakayama-med.ac.jp


Sponsor or person

Institute

Wakayama Medical University, School of Medicine, Second Department of Surgery

Institute

Department

Personal name



Funding Source

Organization

Wakayama Medical University, School of Medicine, Second Department of Surgery

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Wakayama Medical University Hospital

Address

811-1 Kimiidera, Wakayama

Tel

0734410613

Email

tojima@wakayama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 05 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 03 Month 01 Day

Date of IRB

2018 Year 04 Month 01 Day

Anticipated trial start date

2018 Year 04 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 05 Month 08 Day

Last modified on

2019 Year 05 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036918


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name